NDC 71335-2829-01 - mupirocin
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 71335-2829
- Requested NDC
- 71335-2829-01
- Package NDCs from labels
- 71335-2829-1, 71335-2829-01
- Manufacturer
- Bryant Ranch Prepack
- Effective date
- 2025-10-24
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| mupirocin - Bryant Ranch Prepack | Bryant Ranch Prepack | 2025-10-24 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 71335-2829-1 | mupirocin | 22 g in 1 TUBE | OINTMENT | 22 | 100 | |
| 71335-2829-1 | mupirocin | 1 in 1 CARTON | OINTMENT | 1 | 100 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 71335-2829-1 | GM - Gram | 71335-2829 | 15f4b5c6-aed4-4129-a819-54f042c56021 | 1 | 2025-12-16 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| mupirocin | MUPIROCIN | NuCare Pharmaceuticals,Inc. | 831060e6-17ef-b0a0-e053-2991aa0aeb4f | 2026-08-20 | Warnings, Adverse reactions | ANDA065123 106346 D0GX863OA5 |
| mupirocin | MUPIROCIN | Preferred Pharmaceuticals Inc. | 6c9cd7fc-b72e-406e-b9aa-0f1bc035b832 | 2026-07-28 | Warnings, Adverse reactions | ANDA065123 106346 D0GX863OA5 |
| Mupirocin | MUPIROCIN | Preferred Pharmaceuticals Inc. | 06a4ee22-d8f8-4a8a-8666-82b14f2d8476 | 2026-07-28 | Warnings, Adverse reactions | 106346 D0GX863OA5 |
| mupirocin | MUPIROCIN | HAWAII REPACK, INC. | 7eaa296c-3f98-4f11-b4c1-62c2bc22a9a1 | 2026-07-27 | Warnings, Adverse reactions | ANDA065123 106346 D0GX863OA5 |
| mupirocin | MUPIROCIN | St. Mary's Medical Park Pharmacy | 235c4f77-e751-a69f-e063-6394a90a1f96 | 2026-06-10 | Warnings, Adverse reactions | ANDA065123 106346 D0GX863OA5 |
| Mupirocin | MUPIROCIN | Sportpharm LLC | c70dd5d7-6995-4a3d-b19c-9b4a2cfe3da9 | 2026-05-12 | Warnings, Adverse reactions | 106346 D0GX863OA5 |
| MUPIROCIN | MUPIROCIN | DIRECT RX | f88eea1a-2ba1-48bf-96c8-d96d18752aaa | 2026-03-20 | Warnings, Adverse reactions | 106346 D0GX863OA5 |
| Mupirocin | MUPIROCIN | PAI Holdings, LLC dba PAI Pharma | a822d44d-c651-406c-a2b9-aa8fbe8f89ce | 2026-03-17 | Warnings, Adverse reactions | 106346 D0GX863OA5 |
| MUPIROCIN | MUPIROCIN | Redpharm Drug | 49eb7289-c44d-75e1-e063-6294a90a2283 | 2026-02-03 | Warnings, Adverse reactions | 106346 D0GX863OA5 |
| mupirocin | MUPIROCIN | REMEDYREPACK INC. | 290b4e51-59b4-429a-987b-715ac817ef2c | 2026-01-28 | Warnings, Adverse reactions | ANDA065123 106346 D0GX863OA5 |
| Mupirocin | MUPIROCIN | AvPAK | 8b10c706-ae9c-fc76-e053-2a95a90a4c73 | 2026-01-20 | Warnings, Adverse reactions | 106346 D0GX863OA5 |
| Mupirocin | MUPIROCIN | Glenmark Pharmaceuticals Inc., USA | ff7428fb-9ce9-4743-b58c-01a05424a57a | 2025-10-28 | Warnings, Adverse reactions | 106346 D0GX863OA5 |
| mupirocin | MUPIROCIN | Bryant Ranch Prepack | 6cef3abf-9f17-459e-86b9-95896d9620b7 | 2025-10-24 | Warnings, Adverse reactions | ANDA065123 71335-2829-1 71335-2829 71335282901 106346 41ea0113-860c-0690-e063-6294a90a8b86 6cef3abf-9f17-459e-86b9-95896d9620b7 D0GX863OA5 |
| mupirocin | MUPIROCIN | Bryant Ranch Prepack | 7e7675fb-4bfa-46ac-ac1b-0918593d63ee | 2025-10-08 | Warnings, Adverse reactions | ANDA065123 106346 D0GX863OA5 |
| MUPIROCIN | MUPIROCIN | Encube Ethicals, Inc. | 95c302b8-affa-431a-9b89-0506f5a098e6 | 2025-10-08 | Warnings, Adverse reactions | 106346 D0GX863OA5 |
| Mupirocin | MUPIROCIN | Sun Pharmaceutical Industries, Inc. | 900bb675-2f03-47e3-854e-257ec4831332 | 2025-07-07 | Warnings, Adverse reactions | 106346 D0GX863OA5 |
| mupirocin | MUPIROCIN | ATLANTIC BIOLOGICALS CORP. | da2f7d4e-82c6-4790-8eea-3a97e5b30734 | 2025-05-28 | Warnings, Adverse reactions | ANDA065123 106346 D0GX863OA5 |
| Mupirocin | MUPIROCIN OINTMENT | Kesin Pharma Corporation | b8e115ce-c8ff-4d08-b865-71dc4d0e51a1 | 2025-05-28 | Warnings, Adverse reactions | ANDA065123 106346 D0GX863OA5 |
| Mupirocin | MUPIROCIN | Lohxa | 6d59e35c-b262-7940-e053-2991aa0a8908 | 2025-03-25 | Warnings, Adverse reactions | 106346 D0GX863OA5 |
| Mupirocin | MUPIROCIN | NuCare Pharmaceuticals,Inc. | 5abf8c5c-e9c9-3b59-e053-2a91aa0ae394 | 2025-01-02 | Warnings, Adverse reactions | 106346 D0GX863OA5 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.